Literature DB >> 2817947

Tumour necrosis factor-alpha in infectious meningitis.

D Nadal1, D Leppert, K Frei, P Gallo, H Lamche, A Fontana.   

Abstract

During a one year period tumour necrosis factor-alpha (TNF-alpha) was prospectively determined in the cerebrospinal fluid of 49 patients with infectious meningitis. TNF-alpha was found in the cerebrospinal fluid of 15 of 18 patients with bacterial meningitis. In 11 patients who had cerebrospinal fluid positive for TNF-alpha it was detected in only one serum (in low concentration). There was no significant correlation between the concentration of TNF-alpha in cerebrospinal fluid and the patient's age, duration of illness and fever, body temperature, and serum C reactive protein. However, cerebrospinal fluid protein concentrations of greater than or equal to 2 g/l and leucocyte values of greater than or equal to 2.5 X 10(9)/l were more often associated with high TNF-alpha concentrations (greater than or equal to 500 pg/ml). In contrast with bacterial meningitis, none of the 31 samples of cerebrospinal fluid from patients with viral meningitis was positive for TNF-alpha. Thus this investigation supports the conclusion, drawn from animal studies on TNF-alpha in the cerebrospinal fluid, that the presence of TNF-alpha is indicative of bacterial meningitis. Absence of TNF-alpha cerebrospinal fluid, however, was found here not to exclude a bacterial aetiology of the infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817947      PMCID: PMC1792713          DOI: 10.1136/adc.64.9.1274

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

Review 1.  The role of cachectin/TNF in endotoxic shock and cachexia.

Authors:  A Cerami; B Beutler
Journal:  Immunol Today       Date:  1988-01

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

3.  ELISA for quantitation of tumor necrosis factor-alpha in serum.

Authors:  W S Prince; K J Harder; S Saks; B R Reed; A B Chen; A J Jones
Journal:  J Pharm Biomed Anal       Date:  1987       Impact factor: 3.935

4.  Shock and tissue injury induced by recombinant human cachectin.

Authors:  K J Tracey; B Beutler; S F Lowry; J Merryweather; S Wolpe; I W Milsark; R J Hariri; T J Fahey; A Zentella; J D Albert
Journal:  Science       Date:  1986-10-24       Impact factor: 47.728

5.  Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura.

Authors:  E Girardin; G E Grau; J M Dayer; P Roux-Lombard; P H Lambert
Journal:  N Engl J Med       Date:  1988-08-18       Impact factor: 91.245

6.  Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease.

Authors:  A Waage; A Halstensen; T Espevik
Journal:  Lancet       Date:  1987-02-14       Impact factor: 79.321

7.  Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequence and role of encapsulation.

Authors:  V J Quagliarello; W J Long; W M Scheld
Journal:  J Clin Invest       Date:  1986-04       Impact factor: 14.808

8.  Recombinant tumor necrosis factor causes activation of human granulocytes.

Authors:  J W Larrick; D Graham; K Toy; L S Lin; G Senyk; B M Fendly
Journal:  Blood       Date:  1987-02       Impact factor: 22.113

9.  Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.

Authors:  W J Ming; L Bersani; A Mantovani
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

  9 in total
  16 in total

Review 1.  Cytokines, receptors, and inhibitors.

Authors:  G Gehr; T Braun; W Lesslauer
Journal:  Clin Investig       Date:  1992-01

2.  Evidence for intrathecal synthesis of alternative pathway complement activation proteins in experimental meningitis.

Authors:  P F Stahel; K Frei; A Fontana; H P Eugster; B H Ault; S R Barnum
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

Review 3.  Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy.

Authors:  A M van Furth; J J Roord; R van Furth
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

Review 4.  Pathogenesis and pathophysiology of bacterial meningitis.

Authors:  A R Tunkel; W M Scheld
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

5.  Platelet-activating factor augments meningeal inflammation elicited by Haemophilus influenzae lipooligosaccharide in an animal model of meningitis.

Authors:  G C Townsend; W M Scheld
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

6.  Cerebrospinal fluid levels of interleukin-6 and interleukin-12 in children with meningitis.

Authors:  Chia-Chang Hsieh; Jen-Her Lu; Shu-Jen Chen; Cheng-Chou Lan; Wen-Chi Chow; Ren-Bin Tang
Journal:  Childs Nerv Syst       Date:  2008-09-25       Impact factor: 1.475

7.  Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis.

Authors:  Mona Widhe; Mattias Grusell; Christina Ekerfelt; Magnus Vrethem; Pia Forsberg; Jan Ernerudh
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

8.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

9.  Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis.

Authors:  S Ohga; T Aoki; K Okada; H Akeda; K Fujioka; A Ohshima; T Mori; I Minamishima; K Ueda
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

10.  Aseptic meningitis in children: correlation between fever and interferon-gamma level.

Authors:  I Minamishima; S Ohga; E Ishii; C Miyazaki; K Hamada; K Akazawa; K Ueda
Journal:  Eur J Pediatr       Date:  1991-08       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.